ArticleClinical, cosmetic and investigational dermatology2022

Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities.

Jue Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.